The usefulness of metabolic heat measurements in quantifying the response of a solid tumour to anticancer treatment was evaluated. The heat production characteristic of malignant tissues, as measured from human stomach, breast and liver cancer samples, was observed to be inconsistent, and its value could be higher or lower than that of its normal tissue of origin. The various thermal activity responses of an experimental rat hepatoma to hepatic artery ligation, cryotherapy, intra-arterial (i.a) Adriamycin (2.4 mg/ kg), i.a. Norcantharidin (0.5 mg/kg) were next studied. The tumour/liver (T/L) ratio of untreated tumour-bearing rats was 0.83 but this fell to a minimum at 24 h in both the hepatic artery ligation and the cryosurgery groups. In these two groups marked fluctuations in the heat production of normal liver occurred with poor recovery of the T/ L ratio even at 2--3 weeks. In the Adriamycin group, the T/L ratio dropped to a minimum at 5 days, and in the Norcantharidin group, at 3 days. Minimal disturbances in the thermal activity of liver tissue occured in these two chemotherapy groups and the T/L ratio recovered by 3 weeks. Norcantharidin appeared as efficacious as Adriamycin in the treatment of hepatoma when evaluated in terms of thermal activity.
INTRODUCTION
Although constant efforts are made to develop better tests for cancer chemosensitivity [1] [2] [3] , there has been little progress in methods of quantifying the efficacy of chemotherapy on solid tumours. Traditional methods involve the measurement of either the changes in the tumour growth patterns or the prolongation of host survival induced by the treatment [4] . There are, in addition, a wide variety of techniques which have been developed to allow the quantification of the viability of malignant cells in suspension prepared from animal tumours, such as the end-point dilution assays [5] and assays based on colony formation in vivo or in vitro [6] . However, all these require the tedious processes of removal of tumour cells from the original animal, dispersal into single-cell suspensions, enumeration of the cells, and finally, a test of the growth potential of the cells, either in new hosts or in cell culture. In addition, the potential drawback of all these suspension procedures is the danger of selecting a subpopulation that might not be typical of the entire tumour cell population.
A precise method for quantifying treatment efficacy of liver cancer by measuring the glucose oxidation of tumour tissue using a radio-tracer technique was previously developed by the author [7] and used for evaluating the efficacy of Norcantharidin in the treatment of hepatoma [8] . While The present investigation is a sequel to the authors' previous study on the short term efficacy of Norcantharidin in hepatoma [8] . The objectives of the present study are four-fold: (1) to study the feasibility of using microcalorimetric measurements of tissue slices of different organs, both normal and malignant, as overall indices of their metabolic activities, (2) to study the inter-strain and inter-gender variations in thermal activity of rat liver tissue, (3) to determine the tumour/liver ratio of the thermal activity of an experimental hepatoma model in the rat, and (4) 5 mg in size were harvested in duplicate from the gastrocnemius muscle (n 4), spleen (n 3), small gut (n 6), heart (n 3), stomach (n 6), brain (n 3) and liver (n 5) and their thermal activities were measured. In this and all subsequent studies using animal tissues, the results were expressed as the peak power in mJ/g dry weight instead of per g wet weight (Fig. 1) . The dry weight could be calculated once the wet wt./dry wt. ratio was obtained. Since adequate animal tissues were available, it was possible to obtain the wet wt./dry wt. ratio of the various tissues by drying known weights of tissue samples in a hot air oven at 45C for 3 weeks and re-weighing them after drying. 
Normal Organ Tissue Studies
Thermal activity measurements showed that, the peak power (Pmax) of the various tissues studied were, in descending order, 11 .91 +/-2.12 mJ/g dry wt. for brain, 11.17 +/-0.85 mJ/g dry wt. for liver, 8 .05+/-2.30 mJ/g dry wt. for small gut, 6 .08+/-1.25 mJ/g dry wt. for stomach, 5 .84+/-0.74 mJ/g dry wt. for spleen, 3 .03 +/-1.10 mJ/g dry wt. for heart muscle, and 2.09 +/-0.49 mJ/g dry wt. for skeletal muscle (Fig. 1) . The values of the Pmax were correlated with their respective areas under the power curve for the first hour, which represented the total energy dissipated by the tissue specimen in the first hour (Fig. 2) In the cryosurgery group, the T/L ratio dropped by half to 0.40 and then to a minimum of 0.14 (17 % of baseline) at 24 h. There was marked fluctuation of the thermal activity of the liver tissue in the cryosurgery group after treatment (Fig. 3) In the Norcantharidin group the T/L ratio dropped by a quarter to 0.63 in the first hour after treatment. The ratio reached a minimum of 0.22 (27% of baseline) at 3 days. Recovery in the Norcantharidin group was also complete by 3 weeks. In both the Adriamycin and Norcantharidin groups, the thermal activities of the liver were noted to relatively stable throughout the entire experiment (Fig. 4) .
DISCUSSION
Microcalorimetry has the capacity of a general analytical tool for the quantitative assessment of (n 2) (n 2) (n 2) (n 2) (n 2) (n 2) (n 2) (n 2) the overall physical and chemical changes of many living cellular systems [12] including the study of the process of microbial metabolism, the evaluation of erythrocytes in hyperthyroid states, and even for the study of isolated hepatocytes [13] . Modern microcalorimetry has the advantages of good sensitivity and easy automation, making it an excellent method for observation of the overall metabolic activity of cell processes. Knowledge of the difference in heat production between normal and neoplastic cells led to the application of the microcalorimetric method in the monitoring of the response of leukaemia and lymphoma patients to treatment, [14] [15] [16] and subsequently in the prediction of sensitivity of neoplastic cells to chemotherapy [17, 18] .
An extension of the use of microcalorimetry from pure cellular systems to living tissue slices enabled the technique to be used for monitoring small changes in tissue metabolism occurring in in-vivo systems. Asakawa and his colleagues [19, 20] Although it is common knowledge that the metabolism of most malignant tissues were higher than their normal tissues of origin because of exaggerated glycolysis [21] , metabolic heat measurements in this study did not consistently show exaggerated heat production of malignant tissues over their normal counterparts as expected. Of the human cancer specimens examined, heat production from both the gastric and breast carcinoma tissues were found to be more than twice that of their normal counterparts, whereas .hepatocellular carcinoma tissue was only 0.3 that of normal liver tissue.
The tumour/liver ratio in the patient with an embolized liver tumour was noted to be three times as low as the patient without embolization. This last observation however, was consistent with the authors' surmise that metabolic heat measurement could be useful as a bioassay for tumour activity, before and after treatment.
In the authors' previous study, it was shown that the glucose oxidation rate of the rat Morris Hepatoma model (or T/L ratio) was 4.2 times that of normal liver tissue [8] . Yet, in the present study where thermal activity was used as an index of tumour activity, the T/L ratio was only 0.83. This apparent paradox can be explained by the fact that heat production measured in such situations did not represent merely the heat generated from glycolysis alone, but the sum activity of the total physico-chemical processes of the biological system that resulted in heat dissipated to the surrounding medium. Of interest, Monti [15] similarly noted that the heat production in peripheral blood lymphocytes of chronic lymphocytic leukaemia patients was also lower than that of lymphocytes of healthy subjects.
In the palliative treatment of non-resectable primary liver cancers, a variety of therapeutic modalities are currently available. Surgical ligation of the hepatic artery is a traditional method of proven value, but is a once-off treatment with only short-term efficacy because the liver tumour will regain its arterial supply through collaterals some weeks later [22] . Cryosurgical therapy of liver cancers is a relatively new modality, and has shown encouraging results. However, since it is conducted intra-operatively it is also an once-off treatment, but it is possible to combine its use with intra-arterial chemotherapy. In the present study, both these two physical methods of treatment were shown to be more potent as compared with the two forms of intra-arterial chemotherapy. Their maximum effects were seen in 24 hours compared to hepatoma, but the use was limited by its severe toxicity for the mucuous membranes of the gastrointestinal and urinary tract [8] . The analogue Norcantharidin was subsequently developed and it is known to possess significant antihepatoma activity but at the same time relatively free from side-effects, including bone marrow suppression [23] . In an earlier study by the author [8] , it was shown that, when given by the intra-arterial route, Norcantharidin suppressed oxidative glucose metabolism by nearly 50% within one hour of administration. The present study showed that the heat production dropped by only 75% within the first hour but it exerted its maximum effect within 3 days of administration and recovery was complete by 3 weeks.
In conclusion, thermal activity measurement by microcalorimetry is a precise and convenient method of monitoring the long term response of an experimental hepatoma to treatment. The efficacy of physical modes of therapy in the form of arterial ischaemia and cryotherapy appeared more intense and to have a faster onset, when compared to the chemotherapeutic forms of treatment using Adriamycin and Norcantharidin. Norcantharidin, when given intra-arterially in this study, appeared to be at least as efficacious as Adriamycin. The information obtained herein also provided some clues on the pharmacodynamics of intra-arterial Norcantharidin on a hepatoma model, and .the knowledge thus acquired might help to improve scheduling of chemotherapy regimens in the future.
